Statins and outcomes in patients with pneumoniaBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39038.509167.1F (Published 23 November 2006) Cite this as: BMJ 2006;333:1123
Not only healthy user bias
- Eric M Mortensen ([email protected]),
- Marcos I Restrepo, assistant professor of medicine,
- Laurel A Copeland, assistant professor of psychiatry,
- Mary Jo V Pugh, assistant professor of medicine,
- Antonio Anzueto, professor of medicine
- 1University of Texas Health Science Center at San Antonio, 7400 Merton Minter Boulevard (11C6), San Antonio, TX 78229, USA
We read with interest the article on the use of statins for patients with pneumonia.1 Although an important addition to the literature, several issues limit this article's usefulness.
The choice of an outcome measure combining in-hospital mortality and admission to intensive care is curious for a prospective study with such a rich clinical database. Previous research shows that 30 day mortality …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial